Diamorphine-induced attack of paroxysmal hypertension in phaeochromocytoma.
D002395:Catecholamines / Q000378:metabolism; D003501:Cyclizine / Q000627:therapeutic use; D004172:Diplopia / Q000209:etiology; D004562:Electrocardiography; D005244:Fecal Impaction / Q000139:chemically induced; D006261:Headache / Q000209:etiology; D006339:Heart Rate / Q000187:drug effects; D003932:Heroin / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000503:physiopathology; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D010423:Pentazocine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy*; D011217:Practolol / Q000009:adverse effects
D002395:Catecholamines; D003932:Heroin; D008012:Lidocaine; D003501:Cyclizine; D010423:Pentazocine; D011217:Practolol